The future of a pricey malaria program meant to provide cheap drugs for poor patients may be in jeopardy after health officials clashed over its effectiveness in two new reports. In 2010, the Affordable Medicines Facility for malaria was started by groups including United Nations agencies and the Global Fund to Fight AIDS, Tuberculosis and Malaria. It was a pilot project to subsidize artemesinin combination drugs, the most effective treatment for malaria. The initiative cost more than $460 million, mostly funded by the Global Fund, UNITAID, and the Canadian and British governments. It was tested in eight countries: Cambodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania and Uganda. Most of the drugs bought were sold in the private sector, where there are few controls on who gets them.
|
|
|
Asia accounts for 88 percent of all malaria cases and most of the 46,000 annual deaths occurring outside Africa, a new report shows Friday as experts demand more urgency in fighting the deadly disease. Leading scientists and health experts meeting in Sydney this week at the "Malaria 2012: Saving Lives in the Asia-Pacific" conference also want tougher political leadership and regional coordination. Most international efforts to defeat malaria have so far focused on Africa, where the majority of deaths occur. But out of the 3.3 billion people at risk from the mosquito-borne disease, 2.5 billion live outside the African region.
|
The Zimbabwean government has begun indoor residual house spraying for malaria across the country ahead of the transmission season, an official said Monday. Stanford Mashaire, person in charge of malaria case management from the Ministry of Health and Child Welfare, said spraying of houses had begun in all provinces. Read More
|
Also on FightingMalaria.org
|
|
|
|
No comments:
Post a Comment